Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan · Delayed Price · Currency is TWD 85.80
+0.50 (0.59%)
Sep 30, 2025, 1:30 PM CST
Excelsior Medical Market Cap
Excelsior Medical has a market cap or net worth of 14.72 billion as of September 30, 2025. Its market cap has increased by 2.03% in one year.
Market Cap
14.72B
Enterprise Value
15.82B
Revenue
8.65B
Ranking
n/a
PE Ratio
18.69
Stock Price
85.80
Market Cap Chart
Since July 3, 2003, Excelsior Medical's market cap has increased from 2.50B to 14.72B, an increase of 489.08%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 14.63B | 4.15% |
| Dec 31, 2024 | 14.05B | 2.15% |
| Dec 29, 2023 | 13.76B | 37.31% |
| Dec 30, 2022 | 10.02B | 23.23% |
| Dec 30, 2021 | 8.13B | 2.67% |
| Dec 31, 2020 | 7.92B | 14.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 286.16B |
| PharmaEssentia | 189.36B |
| Bora Pharmaceuticals Co., LTD. | 84.40B |
| Lotus Pharmaceutical | 67.06B |
| Lumosa Therapeutics | 48.18B |
| Oneness Biotech | 32.14B |
| Polaris Group | 28.58B |
| Center Laboratories | 27.60B |